UBS Group AG - QUOIN PHARMACEUTICALS LTD ownership

QUOIN PHARMACEUTICALS LTD's ticker is and the CUSIP is 74907L102. A total of 9 filers reported holding QUOIN PHARMACEUTICALS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of QUOIN PHARMACEUTICALS LTD
ValueSharesWeighting
Q2 2022$4,0009,674
+43872.7%
0.00%
Q4 2021$0220.00%
Other shareholders
QUOIN PHARMACEUTICALS LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Renaissance Technologies 64,932$29,0000.00%
UBS Group AG 9,674$4,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 14,392$6,0000.00%
AMERIPRISE FINANCIAL INC 22,000$256,0000.00%
CITIGROUP INC 13,000$6,0000.00%
Citadel Advisors 19,582$9,0000.00%
TWO SIGMA SECURITIES, LLC 16,108$7,0000.00%
HRT FINANCIAL LP 10,229$4,0000.00%
View complete list of QUOIN PHARMACEUTICALS LTD shareholders